avelumab,m6223,bintrafusp
merck,pfizer
['urothelial', 'm6223', 'javelin,bladder', 'bladder', 'avelumab', 'bintrafusp']
#esmo22 updates: m6223 (#tigit) bintrafusp alfa (#tgf-b) failed to show orr, initial response with sd: 38% (m6223 mono) &amp; 12% (combo) m6223 + avelumab combo in urothelial cancer in ph2 javelin bladder medley to be evaluated
#solidtumors #immunooncology #cancer 
Course5i prides itself in enabling #LifeSciences organizations with insights, #analytics and #AI to drive strategic decisions. Enabling better health outcomes.